Materialise NV reported consolidated revenue of EUR 66.259 million for the third quarter of 2025, up 2.2% from the previous quarter but down 3.5% compared to the same period in 2024. Revenue from the Materialise Medical segment increased by 10.3% year-over-year, reaching a quarterly record. The Materialise Software segment reported revenue of EUR 10.286 million, down 7.4% from the third quarter of 2024, while the Materialise Manufacturing segment's revenue decreased 17.1% to EUR 22.677 million. Gross profit for the quarter was EUR 37.651 million, compared to EUR 39.297 million in the third quarter of 2024, with a gross margin of 56.8%. Adjusted EBIT stood at EUR 2.918 million, representing 4.4% of consolidated revenue. Overall operational expenses, including R&D, sales and marketing, and general and administrative costs, totaled EUR 36.019 million, a 0.5% increase from the prior-year period. The net cash position increased by EUR 6.724 million to EUR 67.744 million compared to December 31, 2024.